Open AccessPrognostic Value of Programmed Death Ligand-1 in Discriminating Patients With Lymph Node–Negative, p53–Wild-Type, or Low-BRCA1/2-Expression Pancreatic Ductal Adenocarcinoma
Author(s) -
Xianlong Chen,
Yue Zhang,
Shengwei Mo,
Hui Ma,
Zhaohui Lu,
Shuangni Yu,
Jie Chen
Publication year - 2022
Publication title -
archives of pathology and laboratory medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.79
H-Index - 117
eISSN - 1543-2165
pISSN - 0003-9985
DOI - 10.5858/arpa.2021-0471-oa
Subject(s) - cancer research , stromal cell , tissue microarray , cd8 , lymph node , immunohistochemistry , immune system , foxp3 , pd l1 , immune checkpoint , biology , tumor microenvironment , pathology , medicine , immunotherapy , immunology